About Us
Meet Our Executive Team
Leila Cupersmith is the Founder and CEO of Choice ClinOps and a highly sought after speaker with 20+ years of innovative, hands-on experience successfully leading teams and collaboratively delivering global clinical operations solutions (phases 1 through 3; concept through closure) across 30 countries. Leila with a team of highly experienced fractional industry leaders at Choice ClinOps are ready to partner with you to deliver your cancer or rare disease clinical studies.
Patient-Centered, Patient Safety, Efficacy and Compliance Priority
Patient-centricity, patient safety, efficacy and compliance are key parts of each Choice ClinOps clinical trial solutions action and decision. The clinical trial participant, their caregivers, and future patients are considered in each decision.
Commitment to Consistent Top Quality Service
Commitment to Consistent Top Quality Service
Your projects and vision deserve focused, intential top quality attention and timely responsiveness. Customer satisfaction, quality, and timelieness are 3 of our primary metrics built into each contract. Consistent top quality customer alignment, service, and satisfaction are ingrained in every Choice ClinOps action and decison.